Selective Inhibition of Receptor Tyrosine Kinases by Synthetic Analogues of Aeroplysinin

Angewandte Chemie (International Edition in English)

Volumn 36, Issue 13-14, 1997, Pages 1541-1542

  Waldmann, Herbert ^a   Hinterding, Klaus ^a   Herrlich, Peter ^b   Rahmsdorf, Hans Jobst ^b   Knebel, Axel ^b  

^a UNIVERSITY OF KARLSRUHE   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Aeroplysinin; Bioorganic chemistry; Enzyme inhibitors; Kinases

Indexed keywords

EID: 0030767596     PISSN: 05700833     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.199715411     Document Type: Article

References (33)

1. a) Protein Phosphorylation (Ed.: F. Marks), VCH, Weinheim, 1996;
2. b) Protein Kinases (Ed.: J. R. Woodgett), Oxford University Press, Oxford, 1994;
3. c) G. F. Cooper, Oncogenes, 2nd ed., Jones and Bartlett, Boston, 1995.
4. a) A. Levitzki, A. Gazit, Science 1995, 267, 1782;
5. b) A. Levitzki, Eur. J. Biochem. 1994, 226, 1;
6. c) A. J. Bridges, Chemtracts Org. Chem. 1995, 8, 73;
7. d) D. W. Fry, Annu. Rep. Med. Chem. 1996, 31, 151.
8. For the use of tyrosine kinase inhibitors in the dissection of signaling pathways, see for example ref. [2, 4a, 6] and a) H. Daub, F. U. Weiss, C. Wallasch, A. Ullrich, Nature 1996, 379, 557;
9. b) A. Novogrodsky, A. Vanichin, M. Patya, A. Gazit, N. Osherov, A. Levitzki, Science 1994, 264, 1319;
10. c) N. Meydan, T. Grÿnberger, H. Dadi, M. Shahar, E. Arpaia, Z. Lapidot, J. S. Leeder, M. Freedman, A. Cohen, A. Gazit, A. Levitzki, C. M. Raiffman, Nature 1996, 379, 645;
11. d) D. T. Dudley, L. Pong, S. J. Decker, A. J. Bridges, A. R. Saltiel, Proc. Natl. Acad. Sci. USA 1995, 92, 7686;
12. e) R. A. Lepley, F. A. Kirkpatrick, Arch. Biochem. Biophys. 1996, 337, 141.
13. For recent studies of tyrosine kinase inhibitors, see for example a) E. Buchdunger, J. Zimmermann, H. Mett, T. Meyer, M. Mÿller, U. Regenass, N. B. Lydon, Proc. Natl. Acad. Sci. USA 1995, 92, 2558; b) J. Zimmermann, E. Buchdunger, H. Mett, T. Meyer, N. B. Lydon, P. Traxler, Bioorg. Med. Chem. Lett. 1996, 6, 1221; c) J. Kobayashi, T. Madono, H. Shigemoni, Tetrahedron 1995, 51, 10867; d) K. Alvi, M. C. Diaz, P. Crews, D. L. Slate, R. H. Lee, R. Moretti, J. Org. Chem. 1992, 57, 6604, and citations in ref. [5].
14. For recent studies of tyrosine kinase inhibitors, see for example a) E. Buchdunger, J. Zimmermann, H. Mett, T. Meyer, M. Mÿller, U. Regenass, N. B. Lydon, Proc. Natl. Acad. Sci. USA 1995, 92, 2558; b) J. Zimmermann, E. Buchdunger, H. Mett, T. Meyer, N. B. Lydon, P. Traxler, Bioorg. Med. Chem. Lett. 1996, 6, 1221; c) J. Kobayashi, T. Madono, H. Shigemoni, Tetrahedron 1995, 51, 10867; d) K. Alvi, M. C. Diaz, P. Crews, D. L. Slate, R. H. Lee, R. Moretti, J. Org. Chem. 1992, 57, 6604, and citations in ref. [5].
15. For recent studies of tyrosine kinase inhibitors, see for example a) E. Buchdunger, J. Zimmermann, H. Mett, T. Meyer, M. Mÿller, U. Regenass, N. B. Lydon, Proc. Natl. Acad. Sci. USA 1995, 92, 2558; b) J. Zimmermann, E. Buchdunger, H. Mett, T. Meyer, N. B. Lydon, P. Traxler, Bioorg. Med. Chem. Lett. 1996, 6, 1221; c) J. Kobayashi, T. Madono, H. Shigemoni, Tetrahedron 1995, 51, 10867; d) K. Alvi, M. C. Diaz, P. Crews, D. L. Slate, R. H. Lee, R. Moretti, J. Org. Chem. 1992, 57, 6604, and citations in ref. [5].
16. For recent studies of tyrosine kinase inhibitors, see for example a) E. Buchdunger, J. Zimmermann, H. Mett, T. Meyer, M. Mÿller, U. Regenass, N. B. Lydon, Proc. Natl. Acad. Sci. USA 1995, 92, 2558; b) J. Zimmermann, E. Buchdunger, H. Mett, T. Meyer, N. B. Lydon, P. Traxler, Bioorg. Med. Chem. Lett. 1996, 6, 1221; c) J. Kobayashi, T. Madono, H. Shigemoni, Tetrahedron 1995, 51, 10867; d) K. Alvi, M. C. Diaz, P. Crews, D. L. Slate, R. H. Lee, R. Moretti, J. Org. Chem. 1992, 57, 6604, and citations in ref. [5].
17. a) G. W. Rewcastle, B. D. Palmer, A. M. Thompson, A. J. Bridges, D. R. Cody, H. Zhou, D. W. Frey, A. McMichael, W. A. Denny, J. Med. Chem. 1996, 39, 1823;
18. b) W. Frey, A. J. Kratow, A. McMichael, L. A. Ambroso, J. M. Nelson, W. R. Leopold, R. W. Connors, A. J. Bridges, Science 1994, 265, 1093;
19. c) A. P. Spada, M. R. Myers, Exp. Opin. Ther. Pat. 1995, 5, 805;
20. d) A. J. Bridges, H. Zhou, D. R. Cody, G. W. Rewcastle, A. McMichael, H. D. H. Showalter, D. W. Fry, A. J. Kraker, W. A. Denny, J. Med. Chem. 1996, 39, 267;
21. e) P. Traxler, N. Lydon, Drugs Fut. 1995, 20, 1261.
22. Review: A. Levitzki, FASEB J. 1992, 6, 3275.
23. a) Determination of the biological activity of aeroplysinin 1: M.-H. Kreuter, R. E. Leake, F. Rinaldi, W. Mÿller-Klieser, A. Maidhof, W. E. G. Müller, H. C. Schröder, Comp. Biochem. Physiol. 1990, 978, 151;
24. b) synthesis of 1 and isoaeroplysinin 6: R. J. Andersen, D. J. Faulkner, J. Am. Chem. Soc. 1975, 97, 936
25. (+)-Aeroplysinin was kindly supplied by Prof. Proksch, Lehrstuhl für Pharmazeutische Biologie, Universität Würzburg (Germany).
26. Aldehyde 3 is commercially available.
27. L. F. Fieser, M. Fieser, Reagents for Organic Synthesis, Vol. 1, Wiley, New York, 1967, p. 967.
28. H.-D. Becker, T. Bremholt, E. Adler, Tetrahedron Lett. 1972, 13, 4205.
29. For recent applications of the Becker-Adler oxidation in natural-product synthesis, see a) E. J. Corey, J. P. Dittami, J. Am. Chem. Soc. 1985, 107, 256; b) S. Danishefsky, M. D. Shair, J. Org. Chem. 1996, 61, 16.
30. For recent applications of the Becker-Adler oxidation in natural-product synthesis, see a) E. J. Corey, J. P. Dittami, J. Am. Chem. Soc. 1985, 107, 256; b) S. Danishefsky, M. D. Shair, J. Org. Chem. 1996, 61, 16.
31. W. J. Wasilenko, D. M. Payne, D. L. Fitzgerald, M. J. Weber, Mol. Cell. Biol. 1991, 11, 309.
32. A. Knebel, H. J. Rahmsdorf, A. Ullrich, P. Herrlich, EMBO J. 1996, 15, 5314.
33. The NIH-3T3-β-PDGFR cells were kindly supplied by Prof. Dr. A. Ullrich, Max-Planck-Institut für Biochemie, Martinsried (Germany).